About Activiomics
Activiomics is a Healthcare company based in London (United Kingdom) founded in 2009, and was acquired by hVIVO in March 2014. Phosphoproteomic solutions are offered for biomarker discovery and drug development. Activiomics has raised $805 thousand across 1 funding round from investors including hVIVO and IP Group. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ACTIVIOMICS LIMITED.
Company details
Activiomics was founded in 2009 in London, United Kingdom, focusing on the biotechnology sector. Phosphoproteomic technologies are utilized by the company for biomarker identification and drug development support. The TIQAS platform is employed to quantify phosphopeptides, with cell tissues broken down via protease into fragments and analyzed through mass spectrometry. Acquisition by Retroscreen (now hVivo) occurred in March 2014 for 4 million GBP.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website activiomics.com
- Acquired by hVIVO (Mar 2014)
- Legal Name Activiomics Limited
Funding Insights of Activiomics
Activiomics has successfully raised a total of $805K through 1 strategic funding round. The most recent funding activity was a Seed round of $805 thousand completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $805,000
- Total Rounds 1
- Last Round Seed — $805,000
- First Round $805,000
(Mar 2011)
- Investors Count 1
All 1 funding rounds of Activiomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $805,000 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Activiomics
Activiomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include hVIVO and IP Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and advisory services are offered across multiple sectors. | 2001 | ipgroupplc.com | London, United Kingdom | |
Provider of cell based assays, field trial, and molecular services for biopharma sector | 1998 | hvivo.com | London, United Kingdom |
Investor details for Activiomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Activiomics
3 dated milestones of Activiomics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Activiomics is founded.
- Funding First funding round of $805K.
- Exit Acquired by hVIVO.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Activiomics (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Activiomics
Activiomics was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Activiomics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Activiomics is a funded company, having raised a total of $805K across 1 funding round to date. The company's 1st funding round was a Seed of $805K, raised on Mar 2011.
Activiomics was founded in 2009 in London, United Kingdom, focusing on the biotechnology sector. Phosphoproteomic technologies are utilized by the company for biomarker identification and drug development support. The TIQAS platform is employed to quantify phosphopeptides, with cell tissues broken down via protease into fragments and analyzed through mass spectrometry. Acquisition by Retroscreen (now hVivo) occurred in March 2014 for 4 million GBP.
Activiomics operates through Activiomics Limited.
Yes. Activiomics was acquired by hVIVO in March 2014.